Quadrivalent HPV vaccine effectiveness against high-grade cervical lesions by age at vaccination: A population-based study
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Quadrivalent HPV vaccine effectiveness against high-grade cervical lesions by age at vaccination: A population-based study
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF CANCER
Volume 138, Issue 12, Pages 2867-2874
Publisher
Wiley
Online
2016-02-09
DOI
10.1002/ijc.30035
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Reduction in HPV 16/18-associated high grade cervical lesions following HPV vaccine introduction in the United States – 2008–2012
- (2015) Susan Hariri et al. VACCINE
- The Participation of HPV-Vaccinated Women in a National Cervical Screening Program: Population-Based Cohort Study
- (2015) Eva Herweijer et al. PLoS One
- Risk of first cervical HPV infection and pre-cancerous lesions after onset of sexual activity: analysis of women in the control arm of the randomized, controlled PATRICIA trial
- (2014) Xavier Castellsagué et al. BMC INFECTIOUS DISEASES
- 50 years of screening in the Nordic countries: quantifying the effects on cervical cancer incidence
- (2014) S Vaccarella et al. BRITISH JOURNAL OF CANCER
- Effectiveness of the Quadrivalent Human Papillomavirus Vaccine Against Cervical Dysplasia in Manitoba, Canada
- (2014) Salaheddin M. Mahmud et al. JOURNAL OF CLINICAL ONCOLOGY
- Early Impact of Human Papillomavirus Vaccination on Cervical Neoplasia--Nationwide Follow-up of Young Danish Women
- (2014) B. Baldur-Felskov et al. JNCI-Journal of the National Cancer Institute
- Effectiveness of quadrivalent human papillomavirus vaccine for the prevention of cervical abnormalities: case-control study nested within a population based screening programme in Australia
- (2014) E. Crowe et al. BMJ-British Medical Journal
- Impact of a population-based HPV vaccination program on cervical abnormalities: a data linkage study
- (2013) Dorota M Gertig et al. BMC Medicine
- Quadrivalent Human Papillomavirus Vaccine Effectiveness: A Swedish National Cohort Study
- (2013) Amy Leval et al. JNCI-Journal of the National Cancer Institute
- Human papillomavirus types in 115,789 HPV-positive women: A meta-analysis from cervical infection to cancer
- (2012) Peng Guan et al. INTERNATIONAL JOURNAL OF CANCER
- Impact of human papillomavirus (HPV) vaccination on HPV 16/18-related prevalence in precancerous cervical lesions
- (2012) Suzanne E. Powell et al. VACCINE
- Women's sexual behavior. Population-based study among 65 000 women from four Nordic countries before introduction of human papillomavirus vaccination
- (2011) KIRSTEN EGEBJERG JENSEN et al. ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA
- HPV16 is associated with younger age in women with cervical intraepithelial neoplasia grade 2 and 3
- (2011) L. Baandrup et al. GYNECOLOGIC ONCOLOGY
- Impact of an HPV6/11/16/18 L1 virus-like particle vaccine on progression to cervical intraepithelial neoplasia in seropositive women with HPV16/18 infection
- (2011) Richard M. Haupt et al. INTERNATIONAL JOURNAL OF CANCER
- Age-specific prevalence of HPV genotypes in cervical cytology samples with equivocal or low-grade lesions
- (2009) S Brismar-Wendel et al. BRITISH JOURNAL OF CANCER
- Natural History of Genital Warts: Analysis of the Placebo Arm of 2 Randomized Phase III Trials of a Quadrivalent Human Papillomavirus (Types 6, 11, 16, and 18) Vaccine
- (2009) Suzanne M. Garland et al. JOURNAL OF INFECTIOUS DISEASES
- The completeness of the Swedish Cancer Register – a sample survey for year 1998
- (2008) Lotti Barlow et al. ACTA ONCOLOGICA
- Risk of Female Human Papillomavirus Acquisition Associated with First Male Sex Partner
- (2008) Rachel L. Winer et al. JOURNAL OF INFECTIOUS DISEASES
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now